FIELD: medicine. SUBSTANCE: essence of this method resides in using compositions including lithium compounds with matrix-carrier. This method prescribes using aluminum hydroxide capable of forming LinX·2n Al(OH)3·pH2O compounds with lithium salts, where X represents anion of either inorganic or organic acid, as aluminum hydroxide matrix. EFFECT: psychotropic effect produced by lithium salts (up to 24 48 h) exceeds prior art from 2 to 2.5 times. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF β-SPODUMENE | 1993 |
|
RU2049059C1 |
METHOD FOR PRODUCTION OF PENTALITHIUM ALUMINATE OF β MODIFICATION | 1993 |
|
RU2049726C1 |
METHOD OF LITHIUM α-ALUMINATE PRODUCING | 1991 |
|
SU1816368A3 |
METHOD OF PRODUCING OF LITHIUM PENTALUMINATE LiAlO | 1992 |
|
RU2034784C1 |
PROCESS OF MANUFACTURING PELLETIZED SORBING MATERIAL FOR LITHIUM RECOVERY FROM SALT BRINES | 1992 |
|
RU2009714C1 |
METHOD OF PREPARING γ-LITHIUM ALUMINATE | 1991 |
|
RU2040469C1 |
METHOD OF PRODUCING OF LITHIUM α-ALUMINATE | 1992 |
|
RU2034783C1 |
METHOD OF SEPARATION OF LITHIUM ISOTOPES | 2001 |
|
RU2218205C2 |
METHOD OF PRODUCING COMPOSITION MATERIALS, TRANSIENT METAL-ALUMINIUM OXIDE | 1994 |
|
RU2087418C1 |
METHOD OF PRODUCTION OF LITHIUM GAMMA-ALUMINATE | 2004 |
|
RU2251526C1 |
Authors
Dates
1995-12-27—Published
1992-06-05—Filed